Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute lymphoblastic leukemia

D R Miller

    Pediatric Clinics of North America
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Advances in diagnosis, supportive care, and combination therapies have significantly improved outcomes for childhood leukemia. Current treatments now achieve a 65-70% five-year remission rate for pediatric patients.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oral Health, Inflammation, and Cardiometabolic Factors in the VA Million Veteran Program.

    JDR clinical and translational research·2024
    Same author

    Cerambycid Pheromones Attract Predators Temnoscheila virescens (Coleoptera: Trogossitidae), Chariessa pilosa (Coleoptera: Cleridae), and Apiomerus crassipes (Hemiptera: Reduviidae).

    Environmental entomology·2023
    Same author

    Cerambycid Pheromones 3,2-Hydroxyketones Affect Catches of Some Bark and Ambrosia Beetles (Coleoptera: Curculionidae) in Ethanol-Baited Multiple-Funnel Traps in Southeastern United States.

    Journal of economic entomology·2022
    Same author

    Interactions Between syn- and anti-2,3-Hexanediol Lures on Trap Catches of Woodboring Beetles and Associates in Southeastern United States.

    Environmental entomology·2021
    Same author

    Quantification of endospores in ancient permafrost using time-resolved terbium luminescence.

    Analytical biochemistry·2020
    Same author

    Sulcatol: Enantiospecific Attractant for Monarthrum mali (Coleoptera: Curculionidae: Scolytinae), Leptostylus asperatus (Coleoptera: Cerambycidae) and Associated Predators.

    Environmental entomology·2020
    Same journal

    Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

    Pediatric clinics of North America·2026
    Same journal

    Advancing Pediatric Dermatology: Innovations in Care and Access.

    Pediatric clinics of North America·2026
    Same journal

    No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

    Pediatric clinics of North America·2026
    Same journal

    Telemedicine and Access to Pediatric Dermatology Care.

    Pediatric clinics of North America·2026
    Same journal

    Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

    Pediatric clinics of North America·2026
    Same journal

    Medical Photography's Power to Change Medical Care.

    Pediatric clinics of North America·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Hematology

    Background:

    • Childhood leukemia outcomes have historically been poor.
    • Significant progress has been made in treating pediatric leukemia.

    Purpose of the Study:

    • To review recent advances in childhood leukemia.
    • To highlight factors contributing to improved patient outlook.

    Main Methods:

    • Review of recent biological, diagnostic, and treatment advances.
    • Analysis of factors influencing remission rates.

    Main Results:

    • Improved diagnostic accuracy enhances treatment.
    • Supportive care and prophylactic therapies are crucial.
    • Combination drug therapies maintain remission effectively.
  • Current treatments yield 65-70% five-year continuous remission in children.

    • Conclusions:

    • Multifaceted advances have dramatically improved childhood leukemia prognosis.
    • Continued research in biology, diagnosis, and treatment is vital for further progress.